CRKL is upregulated in many malignancies, such as gastric cancer [23], hepatocellular carcinoma [10,44,45], lung cancer [46,47], and cervical cancer [23], and correlates with a poor disease prognosis. Here, CRKL is linked to lung carcinoma.